Diabetic kidney disease (DKD) imposes a heavy medical burden worldwide due to the lack of effective treatment. High levels of mtROS and mitochondrial damage in the renal tubules are the initiating and ...

Diabetes is a leading cause of chronic kidney disease (CKD) worldwide, and with approximately 4.2 million South Africans ...

Abstract Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk ...

Promising pipeline diabetic nephropathy therapies such as SER150, CU01, 2HPβCD, SC0062, WAL0921, AP 303, YG1805, CTA 382, and others are in different Phases of diabetic nephropathy clinical trials.

Using a diabetic rat model, the researchers found that PEITC helped reduce or even reverse signs of kidney damage. This is ...

The study looked at a drug called spironolactone. It’s normally used to treat high blood pressure, but it’s now showing ...

Researchers have found that women with pregestational diabetes mellitus (PGDM) face a dramatically higher risk of postpartum ...

Diabetes progression indicators, including chronic kidney disease and prolonged diabetes duration, were associated with greater kidney cancer risk.

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no ...

Which is more effective for preventing type 2 diabetes- metformin or lifestyle change? Long-term studies show lifestyle wins- ...

We speak to him about the company’s drive to tackle the complications of type 2 diabetes, such as chronic kidney disease, and how they see the future unfolding with GLP-1 agonists and beyond.

BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...